Has James Lonquist, MD received payments from drug or device companies?

Yes. Drug and device makers reported $45,199 in general payments to James Lonquist, MD across 146 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Lonquist, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Lonquist, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Lonquist, MD

Vascular Surgery · Pensacola, FLNPI 1881694446

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $31,000 of the $45,199 with a category attached, or 68.6%. Atricure, Inc. accounts for 81.9% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $30,502 and has fallen 98.1% since, to $569 in 2025. Among vascular surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,199in general payments, 2019–2025

Across 146 payments — averaging $309.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$37K
Edwards Lifesciences$3K
Cook Incorporated$1K
Abiomed$1K
Abbott$686
Boston Scientific$353
plus $2K from 17 others

$8,500in research payments, 2019–2025

Across 1 payment — averaging $8500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Atricure, Inc.$9K

What the payments were for

Consulting fees$31,00069%
Travel & lodging$5,08411%
Food & beverage$7,71417%
Education$1,4003%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	58	$37,001
Edwards Lifesciences	27	$2,673
Cook Incorporated	3	$1,307
Abiomed	10	$1,263
Abbott	6	$686
Boston Scientific	4	$353
AstraZeneca	5	$306
Medtronic(2 entities)	9	$251
Baxter Healthcare	2	$243
Cook Medical LLC	3	$214
Amgen	2	$164
Kls-martin L.p.	2	$148
E.r. Squibb & Sons, L.L.C.	1	$121
Pfizer	1	$105
LSI Solutions Inc	2	$80
Artivion, Inc.	2	$69
Venclose Inc.	2	$65
Getinge USA Sales, LLC	2	$48
Livanova USA, Inc.	1	$33
CGG Medical Inc	1	$23
Kerecis Limited	1	$18
Cvrx, Inc.	1	$17
Angiodynamics, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,199 in reported general payments places this provider in the 90th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$88,748

Medicare patients

Services billed

271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Tartrate	38	$235

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Pensacola

Geoffrey RisleyPensacola$96K
Christopher LecroyPensacola$35K
Huey McDanielPensacola$35K
Samuel TapperStuart$1.3M
Mariano ArosemenaBradenton$472K
Manuel Perez IzquierdoOrlando$302K
Erin MooreJacksonville$300K
Rajesh MalikNaples$237K
Charles BaileyTampa$162K
Joseph WasselleMelbourne$161K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →